About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Treatment for Merkel Cell Carcinoma Improves Quality Of Life

by Hannah Joy on December 12, 2017 at 12:03 PM
Font : A-A+

New Treatment for Merkel Cell Carcinoma Improves Quality Of Life

Merkel cell carcinoma (MCC) can be treated with the anti-PD-L1 immunotherapy avelumab that delays progression and improves health-related quality of life (HRQoL) of these patients, reveals a new study.

Future Science Group (FSG) announced the publication of an article in Future Oncology that has demonstrated in patients with metastatic Merkel cell carcinoma (mMCC). "MCC is a potentially devastating disease with few therapeutic options for patients until recently. The approval of avelumab and targeting the PD-1/PD-L1 pathway for patients with MCC has provided an important new option, with some patients achieving durable responses with a tolerable safety profile," the authors explained.

Advertisement


In this study, the researchers utilized data from the JAVELIN Merkel 200 Phase II trial. By analyzing these data, the team was able to demonstrate that the reduction of tumor size experienced under treatment with avelumab correlated with improvements in patients' health status, as measured by both generic and skin cancer-specific HRQoL instruments.

"Now we have evidence that treatment with immunotherapy, such as avelumab, may be associated with an improvement in patient quality of life that also appears to be coordinated with lack of disease progression. Our study adds new insights into an important patient-reported outcome that further supports the significance of immunotherapy in patients with MCC," the authors stated.
Advertisement

"MCC is a very aggressive form of skin cancer; therefore, it is surprising that there is a lack of consensus on the most effective treatment strategy", commented Commissioning Editor for Future Oncology, Rachel Jenkins.

"Following on from this, immunotherapy is a key area right now so it is exciting to see that avelumab has shown promise in delaying MCC progression and improving quality of life."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Surgical Treatment Breast Cancer QUALITY OF LIFE Importance Tools for Measuring HRQOL 

Recommended Reading
Merkel Cell Carcinoma
Merkel cell carcinoma is a rare and a highly aggressive primary skin cancer that grows rapidly and ....
Key Oncoprotein in Merkel Cell Carcinoma Identified
The oncoprotein that allows a common and harmless virus to transform healthy cells Merkel Cell ......
Lymph Node Biopsy Proves Effective in Patients With Merkel Cell Carcinoma
Sentinel lymph node biopsy (SNLB) procedure shows positive results in patients with Merkel Cell ......
New Test to Detect Merkel Cell Carcinoma Recurrence
New findings show how immune system marker can help and often outperform imaging studies for ......
Breast Cancer
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use